Stock of Matinas BioPharma Soars on Promising Oral LNC Docetaxel Results
Matinas BioPharma Holdings, a clinical-stage biopharmaceutical company specializing in revolutionary therapies utilizing its lipid nanocrystal (LNC) platform technology, has disclosed encouraging outcomes from an in